Connect with us

Hi, what are you looking for?


Moderna Gains On Deal To Halve Covid Shot Doses, UNICEF Supply Pact

Stock Markets47 minutes ago (Jun 02, 2021 10:46AM ET)

(C) Reuters

By Dhirendra Tripathi

Investing – Moderna (NASDAQ:MRNA) shares rose 4% Wednesday as the company announced two developments, one that will help it halve the doses of its Covid-19 shots and thus reach more people quickly and the second under which it will supply up to 500 million doses of the vaccine to UNICEF through 2022.

It has signed a deal with Switzerland’s Lonza (SIX:LONN) which said a new production line in Geleen, Netherlands, will have capacity to make ingredients for up to 300 million doses annually at 50 micrograms per dose.

Moderna, which has been studying lower-dose versions to help stretch supplies of its vaccine, has been delivering an approved 100-microgram dose to date. Lower doses aren’t approved yet, but the company is hoping they will be.

The drug maker has said early booster shot data for a 50-microgram version showed it helped protect against emerging virus variants. Lower-doses may also be given to children who may not require a full one.

The Pfizer Inc (NYSE:PFE)-BioNTech SE (NASDAQ:BNTX) shot has already been approved for 12-15-year-olds in Europe and the U.S. Moderna is aiming for a similar nod as data showed its shot was found safe.

Under the other announcement, Moderna said it will deliver UNICEF and its procurement partners up to 34 million doses of Covid-19 vaccine in the December quarter and up to 466 million doses in 2022.

Moderna aims to deliver up to 3 billion doses in 2022, up from 800 million to 1 billion doses this year, Reuters said. It has not yet specified the dosing mix.

Moderna Gains On Deal To Halve Covid Shot Doses, UNICEF Supply Pact

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

World News

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered...

World News

George Soros and Bill Gates are part of a consortium acquiring a British developer of rapid-testing technology, including for Covid-19 and tropical diseases,...


If you parked your car in one of the thousands of parking spots across Calgary, there’s a good chance you paid the Calgary Parking...


ForexMay 27, 2021 02:04AM ET (C) Reuters. By Peter Nurse — The dollar edged higher in early European trade Thursday, finding support from...

Disclaimer: it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. Copyright © 2021 Your Morning Voice. All Rights Reserved